Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sage Therapeutic Com (NQ: SAGE )

70.65 USD -5.52 (-7.25%)
Official Closing Price Updated: 5:12 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 844,751
Open 75.13
Bid (Size) 62.62 (1)
Ask (Size) 89.00 (1)
Prev. Close 76.17
Today's Range 69.32 - 75.13
52wk Range 25.01 - 98.39
Shares Outstanding 46,515,858
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the... 
From Business Wire News Releases
Sage Therapeutics to Present at Upcoming Investor Conferences
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases

Performance

YTD
-17.68%
-17.68%
1 Month
-14.53%
-14.53%
3 Month
+3.03%
+3.03%
6 Month
+31.34%
+31.34%
1 Year
+37.72%
+37.72%

More News

Read More
Sage Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
From Business Wire News Releases
Noteworthy Thursday Option Activity: CRSR, GPRO, SAGE
Tags Stocks
From Market News Video
Noteworthy Wednesday Option Activity: TOL, ANIK, SAGE
Tags Stocks
From Market News Video
Recap: Sage Therapeutics Q4 Earnings
Tags SAGE News Market News
From Benzinga
Is Biogen Stock a Buy?
Tags XLV Market News BIIB
From Motley Fool
Why Is Everyone Talking About Biogen Stock?
Tags Market News BIIB SAGE
From Motley Fool
Why Biogen's Q4 Results Were a Bust
Tags BIIB Market News SAGE
From Motley Fool
Tech stocks won’t crash according to this fund manager, dubbed the English Warren Buffett
Tags MSFT PM BDX
From MarketWatch
Noteworthy ETF Outflows: XBI, NTLA, AGIO, SAGE
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.